ResearchMoz

MediPoint: Spinal Fusion - Current and Future Players

GlobalData
Published Date » 2014-06-20
No. Of Pages » 79
   
 Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited immensely from its long history of use, investments in advancing technologies, and its clinical success in a growing variety of spinal conditions. These traits have led spinal fusion surgery to become one of the most frequently performed surgeries in the US, which is undoubtedly, the largest geographic market for this procedure. Given the global phenomenon of an aging society and the associated increasing incidences of degenerative spinal conditions, the spinal fusion market is expected to remain strong over the forecast period. 
   
 The report identifies and analyzes the key companies shaping and driving the Spinal fusion market. The report provides...
Table of Content

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 6
2.1 Overview 6
2.2 Catalyst 6

3 Competitive Assessment 8
3.1 Indications 8
3.2 Classification Based on System 10
3.2.1 Spinal Plating Systems 10
3.2.2 Interbody Cages 11
3.2.3 Pedicle Screw Systems 12
3.3 Company Market Share 13
3.3.1 US 13
3.3.2 5EU 14
3.3.3 APAC 15
3.3.4 South America 16

4 Pipeline Assessment 18

5 Current and Future Players 21
5.1 Overview 21
5.2 Trends in Corporate Strategy 21
5.3 Company Profiles 21
5.3.1 Aesculap 21
5.3.2 Alphatec Spine 24
5.3.3 Amedica Corporation 27
5.3.4 Medtronic Spinal and Biologics 29
5.3.5 DePuy Spine 32
5.3.6 Globus Medical 35
5.3.7 K2M 38
5.3.8 Biomet 41
5.3.9 Stryker 44
5.3.10 Zimmer 47
5.3.11 Nuvasive 51
5.3.12 Orthofix 54
5.3.13 Integra LifeSciences 57

6 Appendix 61
6.1 Bibliography 61
6.2 Abbreviations 71
6.3 Report Methodology 72
6.3.1 Overview 72
6.3.2 Coverage 72
6.3.3 Primary Research 72
6.3.4 Secondary Research 73
6.3.5 Forecasting Methodology 74
6.4 Key Opinion Leaders Included in this Study 75
6.5 About the Authors 76
6.5.1 Joseph A. Gregory, Analyst, Surgical Devices 76
6.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 76
6.6 Global Head of Healthcare 77
6.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 77
6.7 About MediPoint 78
6.8 About GlobalData 78
6.9 Disclaimer 78

List of Tables


Table 1: Indications for Lumbar Spinal Fusion 9
Table 2: Spinal Surgery, US Company Market Share, 2012 13
Table 3: Spinal Surgery, 5EU Company Market Share, 2012 14
Table 4: Spinal Surgery, APAC Company Market Share, 2012 15
Table 5: Spinal Surgery, South American Company Market Share, 2012 16
Table 6: Company Portfolio - Aesculap 22
Table 7: Product Portfolio - Aesculap 23
Table 8: Company Portfolio - Alphatec Spine 25
Table 9: Product Portfolio - Alphatec Spine 26
Table 10: Company Portfolio - Amedica 28
Table 11: Product Portfolio - Amedica 29
Table 12: Company Portfolio - Medtronic Spinal and Biologics 30
Table 13: Product Portfolio - Medtronic Spinal and Biologics 31
Table 14: Company Portfolio - DePuy Spine 33
Table 15: Product Portfolio - DePuy Spine 34
Table 16: Company Portfolio - Globus Medical 36
Table 17: Product Portfolio - Globus Medical 37
Table 18: Company Portfolio - K2M 39
Table 19: Product Portfolio - K2M 40
Table 20: Company Portfolio - Biomet 42
Table 21: Product Portfolio - Biomet 43
Table 22: Company Portfolio - Stryker 45
Table 23: Product Portfolio - Stryker 46
Table 24: Company Portfolio - Zimmer 49
Table 25: Product Portfolio - Zimmer 50
Table 26: Company Portfolio - Nuvasive 52
Table 27: Product Portfolio - Nuvasive 53
Table 28: Company Portfolio - Orthofix 55
Table 29: Product Portfolio - Orthofix 56
Table 30: Company Portfolio - Integra LifeSciences 58
Table 31: Product Portfolio - Integra LifeSciences 59

List of Figures


Figure 1: Spinal Surgery, US Company Market Share, 2012 14
Figure 2: Spinal Surgery, 5EU Company Market Share, 2012 15
Figure 3: Spinal Surgery, APAC Company Market Share, 2012 16
Figure 4: Spinal Surgery, South American Company Market Share, 2012 17

Upcoming Reports:

Poland: barley market
By - Williams and Marshal Strategy
The purpose of the report is to describe the state of the barley market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview...
Manufacturing Execution Systems (MES) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Information technology has become an integrated part of manufacturing process over the last decade. Manufacturing Execution Systems (MES) solutions are integrated software applications that aid manufacturers to schedule, track, analyze and direct operations. Currently, the Manufacturing Execution Systems (MES) offered in the market are integrated with PLM, SCM and ERP applications to offer the visibility, control, and synchronization to allow manufactures transform its processes. Manufacturing Execution Systems (MES) aims at improving the process capability than production...
Outsourced Customer Care Services Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
The global outsourced customer care services market is growing to fulfill new expectations of end client. Companies are realizing customer experience as the real differentiator rather than the product and services offered by the companies. This makes it difficult for companies to achieve competitive differentiation. In addition, customers are becoming more connected than ever. This acts as a driver for market growth. Modernizing customer experience differ from the traditional customer relationship management (CRM). New opportunities are developing owing to more customization offered by...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Nuclear Development Plans in China Gets Fresh Impetus
Mar 5, 2015  
The nuclear development plans of China got a renewed momentum on Wednesday as State Council gave a nod to build new reactors at the nuclear power plant located near Hongyan River. The unit 5 and 6 of the nuclear plant near Hongyan River, located in the northeastern province of Liaoning got approval for construction from the State Council. The council also mentioned that the construction should...
Indian Telecoms Bid at Spectrum War
Mar 5, 2015  
The Indian government on Wednesday managed to mop up nearly INR 60,000 crore with the spectrum auctions off to a wonderful start. Top bidders included Idea Cellular, Bharti Airtel, and Vodafone India who fought tooth and nail to gain secure airwaves in those areas where their licenses were nearing expiration. Reliance Jio Infocomm made a strenuous attempt to acquire as many data airwaves as...
South Korean Pharmaceutical Companies Extend Business with Saudi Arabia
Mar 5, 2015  
Four South Korean pharmaceutical companies will export their products to Saudi Arabia, including anticancer drugs and antibiotics, for the coming five years, South Korea’s Health Ministry informed this Wednesday, as a result of South Korean President Park Geun-hye's business trip to the Saudi Arabia this week. Ascertaining to the export agreement, representatives of these four Korean...
U.K. Government Slow to Stop Pharma R&D Slump
Mar 4, 2015  
When it comes to turnaround strategies, the focal point of the U.K. government is currently the life sciences industry. Recent data however shows that healthcare companies are spending less and less on research and development processes on drugs in the country. The Office of National Statistics released the data earlier this week. It shows the United Kingdom’s drug production...
Sun Pharma Buys Out GSK Australian Opiates Business
Mar 4, 2015  
Global pharmaceutical giant GSK announced on Tuesday that they had come to an agreement with Sun Pharmaceuticals Industries for the latter to buy out the opiates business in Australia owned by GSK. A joint statement was made by the two pharma top companies. The statement said that the companies’ respective wholly owned subsidiaries had already come to an agreement that was...